Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
2.850
+0.070 (2.52%)
At close: Mar 27, 2026
11.33% (1Y)
| Market Cap | 7.35B +2.7% |
| Revenue (ttm) | 763.16M -3.3% |
| Net Income | -175.20M |
| EPS | -0.17 |
| Shares Out | 1.04B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.07 (2.39%) |
| Ex-Dividend Date | n/a |
| Volume | 1,071,000 |
| Average Volume | 1,177,350 |
| Open | 2.790 |
| Previous Close | 2.780 |
| Day's Range | 2.790 - 2.880 |
| 52-Week Range | 2.130 - 5.290 |
| Beta | 0.12 |
| RSI | 40.14 |
| Earnings Date | Mar 30, 2026 |